Consistently, improved performance was observed in the Morris water maze and Barnes maze tests in 3 × Tg mice, further confirming that the therapeutic effect of BDNF overexpression is independent of Aβ and/or p-tau features in all the tested AD model mice. The gene discussed is MAPT; the disease is Alzheimer disease.